H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 41, 2014, Pages 14900-14905

  Liang, Minmin ^a   Fan, Kelong ^a,b   Zhou, Meng ^a,b   Duan, Demin ^a   Zheng, Jiyan ^a   Yang, Dongling ^a   Feng, Jing ^a   Yan, Xiyun ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APOFERRITIN; DOXORUBICIN; NANOPARTICLE;

ANIMAL; BAGG ALBINO MOUSE; BLOOD; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; ENDOCYTOSIS; FEMALE; HT 29 CELL LINE; HUMAN; INJECTION; NEOPLASMS; NUDE MOUSE; PATHOLOGY; TISSUE DISTRIBUTION; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOFERRITINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; ENDOCYTOSIS; FEMALE; HT29 CELLS; HUMANS; INJECTIONS; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; NEOPLASMS; TISSUE DISTRIBUTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84907892280     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1407808111     Document Type: Article

References (43)

1. Salvador-Morales C, Valencia PM, Thakkar AB, Swanson EW, Langer R (2012) Recent developments in multifunctional hybrid nanoparticles: Opportunities and challenges in cancer therapy. Front Biosci (Elite Ed) 4:529-545.
2. Chauhan VP, Jain RK (2013) Strategies for advancing cancer nanomedicine. Nat Mater 12(11):958-962.
3. Gu F, et al. (2008) Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc Natl Acad Sci USA 105(7):2586-2591.
4. Choi CH, Zuckerman JE, Webster P, Davis ME (2011) Targeting kidney mesangium by nanoparticles of defined size. Proc Natl Acad Sci USA 108(16):6656-6661.
5. Ferrari M (2005) Cancer nanotechnology: Opportunities and challenges. Nat Rev Cancer 5(3):161-171.
6. Jain RK, Stylianopoulos T (2010) Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7(11):653-664.
7. Theil EC (1987) Ferritin: Structure, gene regulation, and cellular function in animals, plants, and microorganisms. Annu Rev Biochem 56:289-315.
8. Meldrum FC, Heywood BR, Mann S (1992) Magnetoferritin: In vitro synthesis of a novel magnetic protein. Science 257(5069):522-523.
9. Wong KKW, Mann S (1996) Biomimetic synthesis of cadmium sulfide-ferritin nanocomposites. Adv Mater 8(11):928-932.
10. Klem MT, Mosolf J, Young M, Douglas T (2008) Photochemical mineralization of europium, titanium, and iron oxyhydroxide nanoparticles in the ferritin protein cage. Inorg Chem 47(7):2237-2239.
11. Li L, et al. (2010) Binding and uptake of H-ferritin are mediated by human transferrin receptor-1. Proc Natl Acad Sci USA 107(8):3505-3510.
12. Lin X, et al. (2011) Chimeric ferritin nanocages for multiple function loading and multimodal imaging. Nano Lett 11(2):814-819.
13. Zhen Z, et al. (2013) RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors. ACS Nano 7(6):4830-4837.
14. Zhen Z, et al. (2013) Ferritin nanocages to encapsulate and deliver photosensitizers for efficient photodynamic therapy against cancer. ACS Nano 7(8):6988-6996.
15. Falvo E, et al. (2013) Antibody-drug conjugates: Targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin. Nanoscale 5(24):12278-12285.
16. Li K, et al. (2012) Multifunctional ferritin cage nanostructures for fluorescence and MR imaging of tumor cells. Nanoscale 4(1):188-193.
17. Fan K, et al. (2012) Magnetoferritin nanoparticles for targeting and visualizing tumour tissues. Nat Nanotechnol 7(7):459-464.
18. Yang Z, et al. (2007) Encapsulation of platinum anticancer drugs by apoferritin. Chem Commun (Camb) 7(33):3453-3455.
19. Xing R, et al. (2009) Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin. J Inorg Biochem 103(7):1039-1044.
20. Yan F, Zhang Y, Kim KS, Yuan HK, Vo-Dinh T (2010) Cellular uptake and photodynamic activity of protein nanocages containing methylene blue photosensitizing drug. Photochem Photobiol 86(3):662-666.
21. Domínguez-Vera JM (2004) Iron(III) complexation of Desferrioxamine B encapsulated in apoferritin. J Inorg Biochem 98(3):469-472.
22. Cutrin JC, Crich SG, Burghelea D, Dastrù W, Aime S (2013) Curcumin/Gd loaded apoferritin: A novel "theranostic" agent to prevent hepatocellular damage in toxic induced acute hepatitis. Mol Pharm 10(5):2079-2085.
23. Butts CA, et al. (2009) Identification of a fluorescent general anesthetic, 1-aminoanthracene. Proc Natl Acad Sci USA 106(16):6501-6506.
24. Hainfeld JF (1992) Uranium-loaded apoferritin with antibodies attached: Molecular design for uranium neutron-capture therapy. Proc Natl Acad Sci USA 89(22):11064-11068.
25. Romagnani S (2006) Immunological tolerance and autoimmunity. Intern Emerg Med 1(3):187-196.
26. Uchida M, et al. (2006) Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. J Am Chem Soc 128(51):16626-16633.
27. Jeon JO, et al. (2013) Designed nanocage displaying ligand-specific peptide bunches for high affinity and biological activity. ACS Nano 7(9):7462-7471.
28. Li X, et al. (2012) Epidermal growth factor-ferritin H-chain protein nanoparticles for tumor active targeting. Small 8(16):2505-2514.
29. Dehal PK, et al. (2010) Magnetizable antibody-like proteins. Biotechnol J 5(6):596-604.
30. Kim M, et al. (2011) pH-dependent structures of ferritin and apoferritin in solution: Disassembly and reassembly. Biomacromolecules 12(5):1629-1640.
31. Yang SC, Ge HX, Hu Y, Jiang XQ, Yang CZ (2000) Doxorubicin-loaded poly (butylcyanoacrylate) nanoparticles produced by emulsifier-free emulsion polymerization. J Appl Polym Sci 78(3):517-526.
32. Harrison PM, Arosio P (1996) The ferritins: Molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1275(3):161-203.
33. Arosio P, Ingrassia R, Cavadini P (2009) Ferritins: A family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta 1790(7):589-599.
34. Tan H, et al. (2014) Visual and semi-quantitative analyses of dual-phase breast-specific gamma imaging with Tc-99m-sestamibi in detecting primary breast cancer. Ann Nucl Med 28(1):17-24.
35. Norton L, Simon R, Brereton HD, Bogden AE (1976) Predicting the course of Gompertzian growth. Nature 264(5586):542-545.
36. Frangioni JV (2008) New technologies for human cancer imaging. J Clin Oncol 26(24):4012-4021.
37. Strebhardt K, Ullrich A (2008) Paul Ehrlich's magic bullet concept: 100 years of progress. Nat Rev Cancer 8(6):473-480.
38. Shi J, Xiao Z, Kamaly N, Farokhzad OC (2011) Self-assembled targeted nanoparticles: Evolution of technologies and bench to bedside translation. Acc Chem Res 44(10):1123-1134.
39. Taneichi M, et al. (2006) Antigen chemically coupled to the surface of liposomes are cross-presented to CD8+ T cells and induce potent antitumor immunity. J Immunol 177(4):2324-2330.
40. Chauhan VP, et al. (2012) Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat Nanotechnol 7(6):383-388.
41. Siddik ZH (2002) Mechanisms of action of cancer chemotherapeutic agents: DNA-interactive alkylating agents and antitumour platinum-based drugs. The Cancer Handbook, ed Alison MR (Nature Publishing Group, London), pp 1125-1313.
42. Lown JW (1993) Discovery and development of anthracycline antitumor antibiotics. Chem Soc Rev 22(3):165-176.
43. Bau R, Jin KK (2000) Crystal structure of vinblastine. J ChemSoc Perk T 1(13):2079-2082.